74 results
Page 4 of 4
8-K
EX-99.1
f8rmpch 5x8n2t2r
22 Nov 19
Other Events
6:55am
8-K
EX-99.1
7vzaskg9hjrhm4pq6c
30 Sep 19
EyeGate Enters Into Agreement for $1.9 Million Private Placement
6:55am
8-K
EX-99.1
9pqbn57z bk
23 Sep 19
Other Events
6:57am
8-K
EX-99.1
572nvrhfsmo1
9 Sep 19
Regulation FD Disclosure
6:50am
8-K
EX-99.1
zsfn92btb hl
29 Aug 19
Material Modifications to Rights of Security Holders
12:45pm
8-K
EX-99.1
8o2 az670
14 May 19
EyeGate Pharma Receives Positive Nasdaq Listing Determination
6:55am
8-K
EX-99.1
y898vvkttjso7shrhcbi
12 Dec 18
Regulation FD Disclosure
4:30pm
8-K
EX-99.2
j4h8 9x8eeq5g2oa1
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.1
wtgxhd i1sls4cpimph
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.1
28yaptamiq3wnrk9n
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
EX-99.1
rq9o1a
25 Sep 18
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
6:58am
PRE 14A
aayn4 sg3c
17 May 18
Preliminary proxy
5:21pm
8-K
EX-99.1
goz3 mg6imgbrusd1ip3
16 May 18
EyeGate Pharmaceuticals Announces New Board Member, Steven Boyd
4:40pm